LifePoint Hospitals Coverage Initiated by Analysts at Goldman Sachs Group Inc. (LPNT)
Equities researchers at Goldman Sachs Group Inc. began coverage on shares of LifePoint Hospitals (NASDAQ:LPNT) in a research report issued on Tuesday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $49.00 price target on the stock. Goldman Sachs Group Inc.’s price objective indicates a potential upside of 2.00% from the stock’s previous close.
Shares of LifePoint Hospitals (NASDAQ:LPNT) traded down 0.41% during mid-day trading on Tuesday, hitting $48.04. The stock had a trading volume of 330,887 shares. LifePoint Hospitals has a 52 week low of $34.37 and a 52 week high of $53.29. The stock’s 50-day moving average is $46.43 and its 200-day moving average is $47.9. The company has a market cap of $2.284 billion and a price-to-earnings ratio of 20.07.
LifePoint Hospitals (NASDAQ:LPNT) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.65 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.72 by $0.07. The company had revenue of $894.90 million for the quarter, compared to the consensus estimate of $911.08 million. During the same quarter last year, the company posted $0.83 earnings per share. LifePoint Hospitals’s revenue was up 9.8% compared to the same quarter last year. Analysts expect that LifePoint Hospitals will post $2.78 EPS for the current fiscal year.
LPNT has been the subject of a number of other recent research reports. Analysts at RBC Capital reiterated a “buy” rating on shares of LifePoint Hospitals in a research note to investors on Monday. They now have a $53.00 price target on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of LifePoint Hospitals from $48.00 to $55.00 in a research note to investors on Monday. They now have a “hold” rating on the stock. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of LifePoint Hospitals from $56.00 to $58.00 in a research note to investors on Tuesday, September 24th. They now have an “overweight” rating on the stock. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $49.21.
LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.